Skip to main navigation Skip to search Skip to main content

Cost-effectiveness of adjuvant systemic therapy in low-risk breast cancer patients with nodal isolated tumor cells or micrometastases.

Translated title of the contribution: Cost-effectiveness of adjuvant systemic therapy in low-risk breast cancer patients with nodal isolated tumor cells or micrometastases.
  • M. de Boer
  • , E.M. Adang
  • , K.C.G. van Dycke
  • , JAAM van Dijck
  • , G.F. Borm
  • , S.C. Seferina
  • , C.H.M. van Deurzen
  • , P.J. van Diest
  • , P. Bult
  • , A.R.T. Donders
  • , V.C.G. Tjan-Heijnen

Research output: Contribution to journalArticleAcademicpeer-review

Translated title of the contributionCost-effectiveness of adjuvant systemic therapy in low-risk breast cancer patients with nodal isolated tumor cells or micrometastases.
Original languageUndefined/Unknown
Pages (from-to)2585-2591
Number of pages7
JournalAnnals of Oncology
Volume23
Issue number10
Publication statusPublished - 2012

Cite this